quinoline has been researched along with Anasarca in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdel-Aziz, M; Abdelhamid, D; Dalby, KN; Hassan, HA; Kaoud, TS; Mohassab, AM | 1 |
| Bircher, AJ; Messmer, SL; Rufli, T; Surber, C | 1 |
2 other study(ies) available for quinoline and Anasarca
| Article | Year |
|---|---|
Novel quinoline incorporating 1,2,4-triazole/oxime hybrids: Synthesis, molecular docking, anti-inflammatory, COX inhibition, ulceroginicity and histopathological investigations.
Topics: Animals; Anti-Inflammatory Agents; Binding Sites; Catalytic Domain; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Edema; Enzyme Activation; Gastric Mucosa; Inhibitory Concentration 50; Kinetics; Liver; Molecular Docking Simulation; Nitric Oxide; Oximes; Quinolines; Rats; Structure-Activity Relationship; Triazoles | 2017 |
Delayed-type hypersensitivity to subcutaneous lidocaine with tolerance to articaine: confirmation by in vivo and in vitro tests.
Topics: Adult; Anesthetics, Local; Benzocaine; Bupivacaine; Carticaine; Cross Reactions; Dermatitis, Allergic Contact; Dibucaine; Drug Eruptions; Drug Tolerance; Eczema; Edema; Female; Humans; Hypersensitivity, Delayed; Injections, Subcutaneous; Lidocaine; Lymphocyte Activation; Mepivacaine; Parabens; Patch Tests; Preservatives, Pharmaceutical; Prilocaine; Procaine; Quinolines; Recurrence; Skin Tests; Sulfites; Tetracaine | 1996 |